文献速递主动脉外科

低温循环停跳联合逆行脑灌注半弓置换的长期结局

Long-term outcomes of hemiarch replacement with hypothermic circulatory arrest and retrograde cerebral perfusion.
PubMed 文献 · J Thorac Cardiovasc Surg · 2021-08-03

该观察性研究纳入2010至2018年接受低温循环停跳联合逆行脑灌注半弓置换的500例患者,其中动脉瘤样变占53.0%、急性主动脉夹层占47.0%。全组手术死亡率6.4%、卒中发生率4.6%,5年生存率84.4%±0.02%;动脉瘤亚组5年生存率88.0%±0.02%,夹层亚组80.5%±0.03%。多变量分析显示急性主动脉夹层与动脉瘤相比死亡风险无显著增加(P=.790)。

要点

  • 半弓置换联合逆行脑灌注的手术死亡率为6.4%,卒中发生率为4.6%。
  • 全组5年生存率为84.4%±0.02%,动脉瘤亚组为88.0%±0.02%,夹层亚组为80.5%±0.03%。
  • 急性主动脉夹层并非长期死亡的独立危险因素(P=.790)。

核心结论

  • 低温循环停跳联合逆行脑灌注半弓置换的并发症与死亡率可接受,对急性主动脉夹层可能同样有利。

研究设计与样本

  • 观察性研究,纳入2010至2018年接受半弓置换联合逆行脑灌注的患者500例,排除部分或全弓置换及同期象鼻手术者。

主要发现

  • 全组手术死亡率为6.4%,卒中发生率为4.6%。
  • 急性主动脉夹层组与动脉瘤组的手术死亡率和卒中率相似。
  • 全组5年生存率为84.4%±0.02%,动脉瘤亚组为88.0%±0.02%,夹层亚组为80.5%±0.03%。
  • 多变量Cox分析显示急性主动脉夹层与动脉瘤相比死亡风险无显著增加(P=.790)。

临床怎么用

  • 对于适合半弓置换的主动脉疾病,低温循环停跳联合逆行脑灌注可作为可选策略。
  • 急性主动脉夹层患者采用该术式未显示长期生存劣势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study sought to report outcomes of hemiarch replacement with hypothermic circulatory arrest and retrograde cerebral perfusion, and secondarily, to report outcomes of this operative approach by type of underlying aortic disease. METHODS: This was an observational study of aortic surgeries from 2010 to 2018. All patients who underwent hemiarch replacement with retrograde cerebral perfusion were included, whereas patients undergoing partial or total arch replacement or concomitant elephant trunk procedures were excluded. Patients were dichotomized into 2 groups by underlying aortic disease; that is, acute aortic dissection (AAD) or aneurysmal degeneration of the aorta. These groups were analyzed for differences in short-term postoperative outcomes, including stroke and operative mortality (Society of Thoracic Surgeons definition). Multivariable Cox analysis was performed to identify variables associated with long-term survival after hemiarch replacement. RESULTS: A total of 500 patients undergoing hemiarch replacement with hypothermic circulatory arrest plus retrograde cerebral perfusion were identified, of whom 53.0% had aneurysmal disease and 47.0% had AAD. For the entire cohort, operative mortality was 6.4%, whereas stroke occurred in 4.6% of patients. Comparing AAD with aneurysm, operative mortality and stroke rates were similar across each group. Five-year survival was 84.4% ± 0.02% for the entire hemiarch cohort, whereas 5-year survival was 88.0% ± 0.02% for the aneurysm subgroup and was 80.5% ± 0.03% for the AAD subgroup. On multivariable analysis, AAD was not associated with an increased hazard of death, compared with aneurysm (P = .790). CONCLUSIONS: Morbidity and mortality after hemiarch replacement with hypothermic circulatory arrest plus retrograde cerebral perfusion are acceptably low, and this operative approach may be as advantageous for AAD as it is for aneurysm.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Brown JA, Navid F, Serna-Gallegos D, et al. Long-term outcomes of hemiarch replacement with hypothermic circulatory arrest and retrograde cerebral perfusion. J Thorac Cardiovasc Surg. 2021. PMID: 34420792. doi:10.1016/j.jtcvs.2021.07.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。